BTC $63,798.47 -1.17%
ETH $1,776.20 -2.48%
BNB $585.14 -0.71%
XRP $0.9575 +0.26%
SOL $72.20 +1.75%
TRX $0.3076 +0.54%
DOGE $0.0583 -1.41%
ADA $0.1516 -0.45%
BCH $207.21 +0.39%
LINK $9.10 -0.54%
HYPE $67.84 +1.81%
AAVE $111.10 +2.94%
SUI $0.7193 -0.08%
XLM $0.1373 +0.58%
ZEC $931.18 +5.61%
AAPL $351.36 -0.77%
AMZN $255.15 -2.27%
GOOGL $280.52 -2.87%
MSFT $498.91 -5.05%
META $615.34 -2.37%
NVDA $153.69 -3.70%
TSLA $378.53 -0.66%
SNDK $773.38 -6.63%
INTC $53.88 -3.68%
SPCX $140.68 +2.69%
MU $689.87 -6.23%
AMD $491.00 -4.00%
BTC $63,798.47 -1.17%
ETH $1,776.20 -2.48%
BNB $585.14 -0.71%
XRP $0.9575 +0.26%
SOL $72.20 +1.75%
TRX $0.3076 +0.54%
DOGE $0.0583 -1.41%
ADA $0.1516 -0.45%
BCH $207.21 +0.39%
LINK $9.10 -0.54%
HYPE $67.84 +1.81%
AAVE $111.10 +2.94%
SUI $0.7193 -0.08%
XLM $0.1373 +0.58%
ZEC $931.18 +5.61%
AAPL $351.36 -0.77%
AMZN $255.15 -2.27%
GOOGL $280.52 -2.87%
MSFT $498.91 -5.05%
META $615.34 -2.37%
NVDA $153.69 -3.70%
TSLA $378.53 -0.66%
SNDK $773.38 -6.63%
INTC $53.88 -3.68%
SPCX $140.68 +2.69%
MU $689.87 -6.23%
AMD $491.00 -4.00%

Acurx Pharmaceuticals 董事会批准购买 100 万美元比特币作为储备资产

2024-11-20 20:08:10

ChainCatcher 消息,据 PR Newswire 报道,纳斯达克上市生物制药公司 Acurx Pharmaceuticals 董事会批准购买 100 万美元比特币作为储备资产。

Acurx 总裁兼首席执行官 David P。Luci 表示:“随着对比特币的需求不断增长,以及其作为主要资产类别的接受度不断提高,我们相信,在未来 12 到 18 个月内,比特币将成为一种强大的资金储备资产,以弥补现金短缺。随着比特币 ETF 近期获得批准,以及政府机构和机构投资者日益增长的支持,比特币将成为资金战略的一大补充。比特币的有限供应和抗通胀特性使其成为一种实用的价值储存手段,这一新资金战略是一种金融战略,不会对药物开发总体计划产生影响。”

链捕手ChainCatcher提醒,请广大读者理性看待区块链,切实提高风险意识,警惕各类虚拟代币发行与炒作, 站内所有内容仅系市场信息或相关方观点,不构成任何形式投资建议。如发现站内内容含敏感信息,可点击,我们会及时处理。

app_icon
ChainCatcher 与创新者共建Web3世界